| Megan C Kane, DO | |
|
2 Quincy Dr, Levittown, PA 19057-1924 | |
| (215) 943-1200 | |
| (215) 943-6650 |
| Full Name | Megan C Kane |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Experience | 39 Years |
| Location | 2 Quincy Dr, Levittown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629071048 | NPI | - | NPPES |
| 0073548000 | Other | PA | KEYSTONE IBC |
| 1025441760001 | Medicaid | PA | |
| 040637 | Other | PA | HIGHMARK BLUE SHIELD |
| 19910 | Other | PA | AETNA HMO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS005955L (Pennsylvania) | Secondary |
| 208D00000X | General Practice | OS005955L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lower Bucks Hospital | Bristol, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aria Health Physician Services | 3577467018 | 418 |
News Archive
Domainex Ltd. expands its partnership with Imperial College London, to discover novel therapies that reduce heart muscle damage during heart attacks. The aim is to discover a drug that inhibits the enzyme MAP4K4, which plays a key role in triggering cell death following a heart attack.
According to officials in Cambodia a second outbreak of bird flu has occurred there this year in southeast Prey Veng, the same province where the H5N1 virus killed a boy in April, about 20 km from the Cambodia-Vietnam border.
Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).
Castrate-refractory prostate cancer, which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy.
Medgenics is pleased to announce that it has signed a preclinical development and option agreement with a major international biopharmaceutical company that is a market leader in the field of hemophilia.
› Verified 1 days ago
| Entity Name | Aria Health Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750949806 PECOS PAC ID: 3577467018 Enrollment ID: O20040224000045 |
News Archive
Domainex Ltd. expands its partnership with Imperial College London, to discover novel therapies that reduce heart muscle damage during heart attacks. The aim is to discover a drug that inhibits the enzyme MAP4K4, which plays a key role in triggering cell death following a heart attack.
According to officials in Cambodia a second outbreak of bird flu has occurred there this year in southeast Prey Veng, the same province where the H5N1 virus killed a boy in April, about 20 km from the Cambodia-Vietnam border.
Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).
Castrate-refractory prostate cancer, which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy.
Medgenics is pleased to announce that it has signed a preclinical development and option agreement with a major international biopharmaceutical company that is a market leader in the field of hemophilia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan C Kane, DO Po Box 8500-6335, Philadelphia, PA 19178-6335 Ph: (215) 943-1200 | Megan C Kane, DO 2 Quincy Dr, Levittown, PA 19057-1924 Ph: (215) 943-1200 |
News Archive
Domainex Ltd. expands its partnership with Imperial College London, to discover novel therapies that reduce heart muscle damage during heart attacks. The aim is to discover a drug that inhibits the enzyme MAP4K4, which plays a key role in triggering cell death following a heart attack.
According to officials in Cambodia a second outbreak of bird flu has occurred there this year in southeast Prey Veng, the same province where the H5N1 virus killed a boy in April, about 20 km from the Cambodia-Vietnam border.
Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).
Castrate-refractory prostate cancer, which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy.
Medgenics is pleased to announce that it has signed a preclinical development and option agreement with a major international biopharmaceutical company that is a market leader in the field of hemophilia.
› Verified 1 days ago